Topic

Koselugo (selumetinib)

A collection of 35 issues

How to Get Koselugo (Selumetinib) Covered by Humana in Washington: Complete Prior Authorization Guide

Quick Answer: Getting Koselugo Covered by Humana in Washington Koselugo (selumetinib) requires prior authorization from Humana for pediatric patients ≥1 year with symptomatic, inoperable plexiform neurofibromas in neurofibromatosis type 1 (NF1). The fastest path: submit complete documentation including NF1 diagnosis (ICD-10: Q85.01), baseline LVEF assessment, and proof of inoperability
7 min read

How to Get Koselugo (Selumetinib) Covered by UnitedHealthcare in Virginia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Koselugo Covered by UnitedHealthcare in Virginia UnitedHealthcare requires prior authorization for Koselugo (selumetinib) in Virginia, with automatic approval for pediatric patients under 19 years who have neurofibromatosis type 1 (NF1). For approval, you'll need NF1 diagnosis documentation, proof of symptomatic inoperable plexiform neurofibromas, baseline heart
6 min read

UnitedHealthcare's Coverage Criteria for Koselugo (Selumetinib) in New Jersey: What Counts as "Medically Necessary"?

Answer Box: Getting Koselugo Covered by UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization for Koselugo (selumetinib) under both medical and pharmacy benefits, with no step therapy requirements for pediatric NF1 plexiform neurofibromas. Medical necessity requires confirmed NF1 diagnosis with symptomatic, inoperable plexiform neurofibromas, baseline LVEF assessment, and ophthalmologic evaluation.
5 min read

How to Get Koselugo (selumetinib) Covered by Cigna in Pennsylvania: Prior Authorization Guide and Appeals Process

Answer Box: Getting Koselugo (selumetinib) Covered by Cigna in Pennsylvania Koselugo (selumetinib) requires prior authorization from Cigna for pediatric patients with neurofibromatosis type 1 (NF1) and symptomatic, inoperable plexiform neurofibromas. Your prescriber must document NF1 diagnosis, imaging showing inoperable plexiform neurofibromas, baseline heart function (LVEF), and eye exam results. If
6 min read

How to Get Koselugo (selumetinib) Covered by Aetna (CVS Health) in California: Complete Prior Authorization Guide with Forms and Appeals

Answer Box: Getting Koselugo (selumetinib) Covered by Aetna (CVS Health) in California Who's eligible: Pediatric patients (≥1 year) with neurofibromatosis type 1 (NF1) and symptomatic, inoperable plexiform neurofibromas. Fastest approval path: Submit prior authorization via CVS Caremark portal with complete NF1 documentation, baseline cardiac/eye exams, and surgical
6 min read

The Requirements Checklist to Get Koselugo (Selumetinib) Covered by Cigna in Michigan: Forms, Appeals, and Clinical Criteria

Answer Box: Quick Path to Koselugo Coverage Cigna requires prior authorization (PA) for Koselugo (selumetinib) in pediatric NF1 patients with symptomatic, inoperable plexiform neurofibromas. Initial approvals last 1 year with reauthorization requiring evidence of benefit. Key requirements: confirmed NF1 diagnosis (ICD-10 Q85.01), baseline LVEF evaluation, ophthalmologic exam, and MRI
5 min read